Medra Corporation
MDRA · OTC
6/30/2002 | 3/31/2002 | 12/31/2001 | 9/30/2001 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.07 | 0.13 | 0.00 |
| FCF Yield | -25.16% | -7.19% | -9.09% | -4.67% |
| EV / EBITDA | -1.78 | -12.28 | -7.53 | -11.06 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | -125.97% | 7.99% | -36.16% | 29.52% |
| Cash Conversion Ratio | 0.39 | 0.87 | 0.67 | 0.55 |
| Growth | ||||
| Revenue 3-Year CAGR | 25.05% | 55.42% | 1,045,463.75% | 967,493.14% |
| Free Cash Flow Growth | 43.27% | 18.58% | -38.29% | 3.12% |
| Safety | ||||
| Net Debt / EBITDA | 0.01 | 0.15 | 0.15 | 0.44 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.37 | 0.30 | 1.22 | 0.21 |
| Cash Conversion Cycle | -4.16 | 119.18 | 53.43 | 200.03 |